Loading patent…
AssigneeAlbumin Therapeutics
InventorDaniel C. CARTER
Estimating the term…
A method for treating psoriasis, eczema, acne and like skin conditions for sanitization, pharmaceutical compounding and protection of the skin from extreme environmental conditions is provided wherein serum albumin is applied in an amount effective to treat, reduce the symptoms and improve the appearance of affected skin due to psoriasis, eczema, and acne and like conditions, enhance the delivery performance or stability of pharmaceutical compounding bases, protect the skin from the environment and premature aging, and to lubricate and/or promote the healing of eye after surgical or accidental trauma, when combined with a suitable topical ointment, antibacterial or dermatological agent, pharmaceutical compounding ointment or bases, vehicle, carrier or excipient. The albumin may be used in a suitable form such as an alcohol-based gel.
A method of treating the skin comprising topically applying a composition comprising human serum albumin in an amount effective to treat a skin or scalp condition selected from the group consisting of psoriasis, eczema, acne, chapped lips, and EGRF inhibitor-related cutaneous skin toxicities, or to protect the skin from a condition selected from the group consisting of overexposure to the elements, environmental factors, metabolic, pharmaceutical or other pollutants and premature aging, and a pharmaceutically acceptable vehicle, carrier or excipient to the skin of a subject in need thereof.
The method according to claim 5 wherein the serum albumin in the alcohol gel or solution is at a concentration in the range of about 1 to 250 mg/ml.
A method of preparing the skin for surgical incision comprising topically administering serum albumin with an antimicrobial in a dermatological agent, vehicle, carrier or excipient in an amount affective to sanitize the targeted skin areas.
A method of augmenting the natural albumin concentration of the skin barrier comprising topically applying a composition comprising human serum albumin in an amount effective for protecting targeted areas of the skin against a condition selected from the group consisting of overexposure to the elements, environmental factors, metabolic, pharmaceutical or other pollutants and premature aging, and a pharmaceutically acceptable vehicle, carrier or excipient to the skin of a subject in need thereof.
Dependencies are inferred from the claim text.